A detailed history of Epoch Investment Partners, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Epoch Investment Partners, Inc. holds 58,264 shares of AMGN stock, worth $17 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
58,264
Previous 62,697 7.07%
Holding current value
$17 Million
Previous $20.2 Million 24.83%
% of portfolio
0.08%
Previous 0.09%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$258.78 - $328.31 $1.15 Million - $1.46 Million
-4,433 Reduced 7.07%
58,264 $15.2 Million
Q3 2024

Nov 13, 2024

SELL
$309.38 - $337.38 $410,856 - $448,040
-1,328 Reduced 2.07%
62,697 $20.2 Million
Q2 2024

Aug 13, 2024

SELL
$262.75 - $319.31 $560,971 - $681,726
-2,135 Reduced 3.23%
64,025 $20 Million
Q1 2024

May 14, 2024

SELL
$268.87 - $324.56 $728,637 - $879,557
-2,710 Reduced 3.93%
66,160 $18.8 Million
Q4 2023

Feb 13, 2024

SELL
$255.7 - $288.46 $16.1 Million - $18.1 Million
-62,821 Reduced 47.7%
68,870 $19.8 Million
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $1.06 Million - $1.31 Million
4,839 Added 3.81%
131,691 $35.4 Million
Q2 2023

Aug 11, 2023

SELL
$214.27 - $253.37 $2.67 Million - $3.16 Million
-12,462 Reduced 8.95%
126,852 $28.2 Million
Q1 2023

May 12, 2023

BUY
$225.79 - $275.2 $1.56 Million - $1.9 Million
6,894 Added 5.21%
139,314 $33.7 Million
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $53.7 Million - $68.2 Million
-234,429 Reduced 63.9%
132,420 $34.8 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $1.58 Million - $1.78 Million
-7,045 Reduced 1.88%
366,849 $82.7 Million
Q2 2022

Aug 15, 2022

SELL
$230.71 - $256.74 $18.9 Million - $21 Million
-81,972 Reduced 17.98%
373,894 $91 Million
Q1 2022

May 13, 2022

BUY
$219.27 - $242.57 $1.49 Million - $1.65 Million
6,789 Added 1.51%
455,866 $110 Million
Q4 2021

Feb 11, 2022

BUY
$198.88 - $227.6 $3.85 Million - $4.4 Million
19,349 Added 4.5%
449,077 $101 Million
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $63.4 Million - $74.3 Million
-298,879 Reduced 41.02%
429,728 $91.4 Million
Q2 2021

Aug 13, 2021

SELL
$233.58 - $259.14 $25.9 Million - $28.8 Million
-111,033 Reduced 13.22%
728,607 $178 Million
Q1 2021

May 17, 2021

BUY
$221.91 - $258.6 $10.6 Million - $12.4 Million
47,787 Added 6.03%
839,640 $209 Million
Q4 2020

Feb 12, 2021

SELL
$216.38 - $257.67 $23.3 Million - $27.8 Million
-107,726 Reduced 11.98%
791,853 $182 Million
Q3 2020

Nov 13, 2020

SELL
$234.65 - $260.95 $21.7 Million - $24.2 Million
-92,633 Reduced 9.34%
899,579 $229 Million
Q2 2020

Aug 13, 2020

SELL
$197.81 - $242.74 $10.7 Million - $13.1 Million
-53,938 Reduced 5.16%
992,212 $234 Million
Q1 2020

May 14, 2020

SELL
$182.24 - $241.7 $35.7 Million - $47.4 Million
-196,019 Reduced 15.78%
1,046,150 $212 Million
Q4 2019

Feb 13, 2020

BUY
$189.21 - $243.2 $25.3 Million - $32.5 Million
133,689 Added 12.06%
1,242,169 $299 Million
Q3 2019

Nov 13, 2019

BUY
$174.11 - $208.62 $68.6 Million - $82.2 Million
394,030 Added 55.15%
1,108,480 $215 Million
Q2 2019

Aug 13, 2019

BUY
$166.7 - $195.41 $4.62 Million - $5.42 Million
27,744 Added 4.04%
714,450 $132 Million
Q1 2019

May 14, 2019

BUY
$180.87 - $203.88 $29.4 Million - $33.1 Million
162,330 Added 30.96%
686,706 $130 Million
Q4 2018

Feb 13, 2019

BUY
$178.4 - $208.25 $78.9 Million - $92 Million
441,995 Added 536.53%
524,376 $102 Million
Q3 2018

Nov 13, 2018

SELL
$185.29 - $208.89 $3.64 Million - $4.11 Million
-19,661 Reduced 19.27%
82,381 $17.1 Million
Q2 2018

Aug 13, 2018

SELL
$166.05 - $186.51 $1.35 Million - $1.52 Million
-8,142 Reduced 7.39%
102,042 $18.8 Million
Q1 2018

May 14, 2018

SELL
$169.43 - $198.0 $557,932 - $652,014
-3,293 Reduced 2.9%
110,184 $18.8 Million
Q4 2017

Feb 13, 2018

BUY
$168.79 - $188.59 $2.11 Million - $2.36 Million
12,516 Added 12.4%
113,477 $19.7 Million
Q3 2017

Nov 13, 2017

BUY
$167.29 - $191.0 $16.9 Million - $19.3 Million
100,961
100,961 $18.8 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $156B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Epoch Investment Partners, Inc. Portfolio

Follow Epoch Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Epoch Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Epoch Investment Partners, Inc. with notifications on news.